TriSalus Life Sciences(TLSI)
$2.52+0.22 (+9.57%)
TLSI
TriSalus Life Sciences financials statements
$2.52
At close:+0.22 (+9.57%)
Want to see TLSI full AI Analyst Report?
TriSalus Life Sciences (TLSI) Income Statement
94 Followers
TriSalus Life Sciences Income Statement
Last quarter (Q3 2026), TriSalus Life Sciences's total revenue was $12.88M, an increase of 11.34% from the same quarter last year. In Q3, TriSalus Life Sciences's net income was $-8.85M. See TriSalus Life Sciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 45.15M | $ 29.43M | $ 18.51M | $ 12.40M | $ 8.40M | |
| $ 38.19M | $ 25.33M | $ 15.91M | $ 10.14M | $ 7.21M | |
| $ 65.13M | $ 61.49M | $ 70.38M | $ 46.58M | $ 31.24M | |
| Depreciation and Amortization | $ 626.00K | $ 744.00K | $ 684.00K | $ 398.00K | $ 464.00K |
| $ -33.05M | $ -32.38M | $ -58.65M | $ -46.78M | $ -26.62M | |
| $ -26.95M | $ -36.16M | $ -54.48M | $ -36.44M | $ -24.03M | |
| $ -12.27M | $ 6.13M | $ -4.88M | $ -10.74M | $ -4.81M | |
| $ -39.22M | $ -30.04M | $ -59.35M | $ -47.18M | $ -28.84M | |
| $ -39.23M | $ -33.23M | $ -59.36M | $ -47.19M | $ -28.84M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.84 | $ -1.25 | $ -2.23 | $ -1.59 | $ -0.92 |
| Diluted EPS | $ -1.84 | $ -1.25 | $ -2.23 | $ -1.59 | $ -0.92 |
| Weighted Average Shares Outstanding | 37.90M | 26.50M | 26.47M | 29.61M | 31.25M |
| Weighted Average Shares Outstanding (Diluted) | 37.90M | 26.50M | 26.47M | 29.61M | 31.25M |
Currency in USD
